choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Synflorix

Synflorix Newsletter
  • Pneumococcal Vaccine Market to Reach USD $11.9 Billion by 2029 at 6.1% CAGR 08 Dec 2025 00:00 GMT

    … Inc. • Sanofi S.A. • GlaxoSmithKline plc • Astellas Pharma Inc. • CSL Limited • Anhui … and previously vaccinated. The U.S. Food and Drug Administration (FDA … Formulation, Adult Formulation 2) By Synflorix: Pediatric Formulation, Adult Formulation …

  • Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine 17 Mar 2025 12:00 GMT

    … Former Chair of GSK’s vaccine business and Chief … deep expertise in drug development and company creation … to investments in big pharma and biotechnology companies. … Rotarix®, and Synflorix® are registered trademarks of GlaxoSmithKline, PLC. Contacts …

  • Pneumococcal Vaccine Global Market Projected to Reach $12.12 Billion by 2029 06 Feb 2025 23:05 GMT

    … for effective vaccines. • Widespread application of vaccines: The pneumococcal vaccine stimulates the … 1) Product Type: Prevnar 13, Synflorix, Pneumovax23, Other Products 2) … Inc., Sanofi S.A., GlaxoSmithKline plc, Astellas Pharma Inc., CSL Limited, Anhui …

  • Pneumococcal Vaccine Market Forecast to Surge to US$ 14.43 Billion by 2032, Achieving a Remarkable 6.4% CAGR 10 Jan 2025 13:11 GMT

    … , impacting the pneumococcal vaccine market growth favorably. 𝐖𝐡𝐨 𝐌𝐚𝐤𝐞𝐬 𝐏𝐧𝐞𝐮𝐦𝐨𝐜𝐨𝐜𝐜𝐚𝐥 𝐕𝐚𝐜𝐜𝐢𝐧𝐞? • GSK plc • Pfizer Inc … • Pneumococcal conjugate vaccine • Pneumococcal polysaccharide vaccine By Product Outlook • Prevnar 13 • Synflorix • Pneumovax23 …

  • Navigating the Future: US Pneumococcal Vaccine Market to Sail to US$ 6,511.79 Million by 2034 with a 2.3% CAGR 10 Dec 2024 13:29 GMT

    … Sanofi • GlaxoSmithKline plc • CSL Behring • Serum Institute • Astellas Pharma US, Inc … 13 • Synflorix • Pneumovax23 By Vaccine Type Outlook • Pneumococcal conjugate vaccine (PCV) … /angina-pectoris-drugs-market Liposomal Doxorubicin Market …

  • Europe Pneumococcal Vaccine Market Set to Boom Anticipating Explosive 5.7% CAGR Growth, Surpass $2.9 Billion by 2032 20 Nov 2024 12:25 GMT

    … 𝐩𝐧𝐞𝐮𝐦𝐨𝐜𝐨𝐜𝐜𝐚𝐥 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐩𝐨𝐫𝐭𝐫𝐚𝐲𝐞𝐝 𝐛𝐲 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬. 𝐓𝐡𝐞 𝐭𝐨𝐩 𝐦𝐚𝐫𝐤𝐞𝐭 𝐜𝐨𝐧𝐭𝐞𝐧𝐝𝐞𝐫𝐬 𝐬𝐮𝐜𝐡 𝐚𝐬: • Astellas Pharma Inc • CSL Ltd • GSK plc • Merck & Co … Vaccines • Pneumococcal Polysaccharide Vaccines By Product Outlook • Prevnar 13 • Synflorix …

  • Second Stage of Anti-Pneumococcal Vaccination in Las Tunas 01 Nov 2024 20:16 GMT

    … municipalities. “,” developed by the Finlay Vaccine Institute, protects against seven of … acquire the two commercial vaccines Prevenar 13 and Synflorix, available in the … manufacture. With the Quimi-Vio vaccine, the island gained technological sovereignty …

  • Synflorix 10 Oct 2024 14:23 GMT

    Pneumococcal polysaccharide serotype 23F / Pneumococcal polysaccharide serotype 4 / Pneumococcal polysaccharide serotype 5 / Pneumococcal polysaccharide serotype 6B / Pneumococcal polysaccharide serotype 7F / Pneumococcal polysaccharide …

  • Global Pneumococcal Vaccine Market Set for Robust Expansion, Projected to Reach $11.36 Billion by 2028 09 Jul 2024 11:11 GMT

    … GlaxoSmithKline PLC, and more. These companies are focusing on developing conjugate vaccines … • Product Type: Prevnar 13, Synflorix, Pneumovax23, Other Products • Route … , Subcutaneous • Distribution Channel: Pharmacies, Community Clinics, Public Health …

  • Pneumonia Vaccine Market Dynamics: Strategic Analysis and Growth Forecasts by 2032 18 Jun 2024 13:08 GMT

    … pneumonia vaccination. Collaborations and Partnerships: Collaborations between pharmaceutical companies, … Vaccine, and Pneumococcal Polysaccharide Vaccine By Product Type: Prevnar 13, Synflorix … in the Market are: Glaxosmithkline, LG Chem, Merck, …

Satisfied with the content?

Continue to create your account.